With a focus on medical and healthcare applications, HWI has expertise in the fields of electronics, firmware, software, electromechanical, IoT, RF, ASIC and microminiature design
SteriPack Group has acquired Colorado-based research, development and engineering service company HWI. (Credit: SteriPackGroup)
SteriPack Group has acquired Colorado-based research, development and engineering service company Halleck-Willard (HWI) to expand its medical device design capabilities.
With a focus on medical and healthcare applications, HWI has expertise in the fields of electronics, firmware, software, electromechanical, robotics, Internet of Things (IoT), radio frequency (RF), an application-specific integrated circuit (ASIC) and microminiature design.
Since 1984, the company has been offering medical device design services that meet the requirements of the US Food and Drug Administration (FDA).
By integrating holistic product lifecycle management services, the combined entity is expected to offer innovative and responsive design, development and contract manufacturing solutions.
SteriPack CEO Andrew McLean said: “HWI will enhance SteriPack’s capabilities as more medical devices and products require specialist design services incorporating embedded systems development, IoT full stack development, RF communications and even rapid prototyping.
“This acquisition augments SteriPack’s suite of product lifecycle services, commencing with new ideas all the way through navigating the regulatory process, to manufacturing, sterilization and supply chain management.”
HWI president Michael Halleck said: “HWI has a history of innovation and collaboration that will continue and grow with SteriPack’s capabilities and global network. We are excited to become the electronic and software design center for SteriPack, serving existing and new clients.”
With operations in more than 50 countries, SteriPack provides contract manufacturing services ranging from initial concept to finished product.
The company serves customers in medical device, diagnostic, pharmaceutical, and allied healthcare industries.
In August this year, the US Department of Defense (DoD) awarded a $14.7m contract to SteriPack to develop domestic production capability for XpressCollect used in support of diagnostic testing for COVID-19.